Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109116

Long-Term Regulation of Adipocyte Glucose Transport Capacity by Circulating Insulin in Rats

Masashi Kobayashi and Jerrold M. Olefsky

Department of Medicine, Stanford University School of Medicine, Stanford University, Stanford, California 94305

Find articles by Kobayashi, M. in: PubMed | Google Scholar

Department of Medicine, Stanford University School of Medicine, Stanford University, Stanford, California 94305

Find articles by Olefsky, J. in: PubMed | Google Scholar

Published July 1, 1978 - More info

Published in Volume 62, Issue 1 on July 1, 1978
J Clin Invest. 1978;62(1):73–81. https://doi.org/10.1172/JCI109116.
© 1978 The American Society for Clinical Investigation
Published July 1, 1978 - Version history
View PDF
Abstract

We have tested the idea that the circulating plasma insulin level plays an important role in the long-term regulation, or maintenance, of the cellular glucose transport system, distinct from insulin's ability to acutely accelerate glucose transport. To study this hypothesis, groups of rats were made either hyperinsulinemic or hypoinsulinemic by daily insulin injections, or streptozotocin treatment, respectively. Different levels of hypoinsulinemia were produced by using different doses of streptozotocin (40 and 55 mg/kg). The mean (±SE) 9 a.m. plasma insulin level for each experimental group was: hyperinsulinemic animals, 65±5 μU/ml; controls, 32±3 μU/ml; low dose streptozotocin group, 18±3 μU/ml; and high dose streptozotocin group 5±2 μU/ml. Isolated adipocytes were prepared from each animal and glucose transport was assessed by measuring the initial rates of uptake of the nonmetabolyzable hexose 2-deoxy glucose. The Vmax and Km values for adipocyte glucose transport were calculated from the 2-deoxy glucose uptake data. The results demonstrated that in cells from control animals the Vmax of in vitro adipocyte glucose transport was 7.1±0.7 nmol/min per 106 cells in the basal state and 22.9±0.9 nmol/min per 106 cells in the presence of a maximally effective insulin concentration (25 ng/ml) in the buffer. In cells from the experimentally hyperinsulinemic animals these Vmax values were increased to 11.7±0.8 and 44.2±1.1 nmol/min per 106 cells. Using adipocytes from both groups of streptozotocin-treated (high dose, 55 mg/kg; low dose, 40 mg/kg) insulin-deficient diabetic animals, Vmax values were found to be progressively decreased. Thus, in the low dose group, basal-and insulin-stimulated Vmax values were 1.6±0.5 and 5.7±0.7 nmol/min per 106 cells, as compared to values of 0.9±0.2 and 1.7±0.6 in the high dose group. Thus, when considered as group data a positive relationship was found between circulating plasma insulin levels and adipocyte glucose transport Vmax, with increased Vmax values in hyperinsulinemic rats and decreased Vmax values in hypoinsulinemic rats. Furthermore, when the individual data were analyzed, highly significant correlation coefficients were found between the height of the plasma insulin level and both the basal (r = 0.82, P < 0.001) and insulin-stimulated (r = 0.93, P < 0.001) Vmax values. The apparent Km for 2-deoxy glucose uptake was the same under all conditions.

In conclusion, assuming that the Vmax of transport is some function of the number of glucose transport carriers per cell, then these results support the hypothesis that in addition to acute acceleration of glucose transport, insulin is also an important long-term regulator of the number of available adipocyte glucose transport carriers.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 73
page 73
icon of scanned page 74
page 74
icon of scanned page 75
page 75
icon of scanned page 76
page 76
icon of scanned page 77
page 77
icon of scanned page 78
page 78
icon of scanned page 79
page 79
icon of scanned page 80
page 80
icon of scanned page 81
page 81
Version history
  • Version 1 (July 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts